Edwards Lifesciences (EW) Minority Interest (2023 - 2025)

Edwards Lifesciences' Minority Interest history runs 3 years deep, the most recent figure standing at $61.2 million for Q2 2025.

• On a quarterly basis, Minority Interest fell 8.93% year-over-year to $61.2 million in Q2 2025; TTM through Jun 2025 was $61.2 million, a 8.93% decrease from a year earlier, with the FY2024 full-year figure at $64.5 million, down 7.06% from the prior year.
• Minority Interest slipped to $61.2 million in Q2 2025 per EW's latest filing, from $62.9 million in the prior quarter.
• Across five years, Minority Interest topped out at $84.0 million in Q1 2023 and bottomed at $61.2 million in Q2 2025.
• The 3-year median for Minority Interest is $67.8 million (2024), against an average of $68.4 million.
• Biggest YoY gain for Minority Interest was 5.08% in 2024; the steepest drop was 18.45% in 2024.
• Year by year, Minority Interest stood at $69.4 million in 2023, then slipped by 7.06% to $64.5 million in 2024, then dropped by 5.12% to $61.2 million in 2025.
• Per Business Quant, the three latest EW Minority Interest figures stand at $61.2 million (Q2 2025), $62.9 million (Q1 2025), and $64.5 million (Q4 2024).